HighVista Strategies »

Aura Biosciences shares owned by HighVista Strategies

Quarter-by-quarter ownership of Aura Biosciences (AURA) shares owned by HighVista Strategies from 13F filings

Historical chart of HighVista Strategies investment in Aura Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Aura Biosciences held by HighVista Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aura Biosciences by HighVista Strategies

Quarter filed Position value Share count Share price at filing
2025-09-30 $168k 27k 6.18

More positions owned by HighVista Strategies

Invesco Db Commdy Indx Trck Unit (DBC)
Abivax Sa Sponsored Ads (ABVX)
Merus N V (MRUS)
Miragen Therapeutics (VRDN)
Revolution Medicines (RVMD)
Protagonist Therapeutics (PTGX)
Nuvalent Inc-a (NUVL)
Mineralys Therapeutics (MLYS)
Arcellx Common Stock (ACLX)
Agios Pharmaceuticals (AGIO)
Cytokinetics Com New (CYTK)
Insmed Com Par $.01 (INSM)
Cidara Therapeutics Com New (CDTX)
Cogent Biosciences (COGT)
Structure Therapeutics Sponsored Ads (GPCR)

View all positions for HighVista Strategies

Top funds holding Aura Biosciences

Matrix Capital Management Company
Frazier Life Sciences Management
Adage Capital Partners GP
Long Focus Capital Management
Suvretta Capital Management
BlackRock
Medicxi Ventures Management
Vanguard Group
Franklin Resources
Nantahala Capital Management
Levin Capital Strategies
Geode Capital Management
UBS Group
State Street Corporation
Regency Capital Management

View all funds holding Aura Biosciences